Molecular characterisation of and mutations in a central South African adult acute myeloid leukaemia cohort.

Background: Recognition of molecular abnormalities in acute myeloid leukaemia (AML) has improved our understanding of its biology. and ITD mutations are recurrent in AML and clinically significant. mutations are associated with a favourable prognosis, while ITD mutations are an independent poor prognostic factor in AML.